risperidone / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 5 Diseases   67 Trials   67 Trials   4266 News 


«12...2223242526272829303132...6364»
  • ||||||||||  risperidone / Generic mfg.
    Clinical, Journal:  Risperidone-induced bruise-like rash in a child. (Pubmed Central) -  Sep 19, 2021   
    This is especially important for pediatric cases where physical abuse may be suspected. SIMILAR CASES PUBLISHED: None.
  • ||||||||||  risperidone / Generic mfg.
    Journal:  Interaction of graphene with antipsychotic drugs: Is there any charge transfer process? (Pubmed Central) -  Sep 16, 2021   
    The charge transfer is more significant with risperidone than with dopamine, and this could be related to the mechanism of action. This is in agreement with the working hypotheses that establish that it is possible to distinguish between agonists and antagonists since they have different capacity to transfer charge.
  • ||||||||||  risperidone / Generic mfg.
    Journal:  Cotard Syndrome in an Adolescent With a First Episode of Psychosis. (Pubmed Central) -  Sep 12, 2021   
    The patient's rapid response to risperidone is unique, as most existing evidence suggests that electroconvulsive therapy is the most effective treatment for Cotard syndrome. This response indicates an opportunity for the implementation of a second-generation antipsychotic medication in patients with Cotard syndrome in areas where electroconvulsive therapy is not available.
  • ||||||||||  risperidone / Generic mfg.
    Preclinical, Journal, PD(L)-1 Biomarker, IO biomarker:  Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression. (Pubmed Central) -  Sep 11, 2021   
    The enhancement of PD-L1 in GBM was antagonized by paliperidone and risperidone as well as DRD2 selective inhibitor L741426...The present study suggests that DRD2 may be involved in regulating the PD-L1 expression in GBM and the microenvironment of GBM. Our results provide a valuable therapeutic strategy and indicate that treatments combining DRD2 antagonist paliperidone with standard immunotherapy may be beneficial for GBM treatment.
  • ||||||||||  aripiprazole / Generic mfg., risperidone / Generic mfg., amisulpride / Generic mfg.
    Clinical, Review, Journal:  Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review. (Pubmed Central) -  Sep 9, 2021   
    A possible risk might be APZ's unique mechanism of action and its association with akathisia. Following up patients with serial Abnormal Involuntary Movement Scale after antipsychotic discontinuation is recommended.
  • ||||||||||  risperidone / Generic mfg., lurasidone / Generic mfg.
    Journal:  Contrasting Typical and Atypical Antipsychotic Drugs. (Pubmed Central) -  Sep 7, 2021   
    These advantages of the atypical APDs in efficacy and safety are due, in part, to initiation of synaptic plasticity via direct and indirect effects of the atypical APDs on a variety of proteins, especially G proteins, and release of neurotrophins (e.g., brain-derived neurotrophic factor). The typical APDs beneficial effects on psychosis are mainly the result of D receptor blockade, which can be associated with serious side effects and lack of tolerability.
  • ||||||||||  risperidone / Generic mfg.
    Clinical, Journal:  Frequency and Correlates of Acute Dystonic Reactions After Antipsychotic Initiation in 441 Children and Adolescents. (Pubmed Central) -  Sep 4, 2021   
    SGAs and low-potency FGA monotherapy in children and adolescents were associated with a relatively low ADR risk, whereas high- and mid-potency FGAs were associated with a high risk. Independent predictors of ADRs were antipsychotic polypharmacy, inpatient treatment, FGAs, and schizophrenia or bipolar disorder diagnoses, which may be related to more aggressive antipsychotic dosing.
  • ||||||||||  risperidone / Generic mfg.
    Clinical, Journal:  Window to His World: Using a Patient's YouTube Channel to Help Diagnose Chronic Mania. (Pubmed Central) -  Sep 3, 2021   
    To our knowledge, this is the first case in the literature in which an online video-sharing service was used longitudinally to facilitate diagnosis of a mental illness. We suggest that technology has great potential to improve our diagnostic tools, especially for disorders such as chronic mania the diagnosis of which relies primarily on self-report and collateral information.
  • ||||||||||  risperidone / Generic mfg.
    Clinical, Journal:  Commentary on "Window to His World: Using a Patient's YouTube Channel to Help Diagnose Chronic Mania". (Pubmed Central) -  Sep 3, 2021   
    To our knowledge, this is the first case in the literature in which an online video-sharing service was used longitudinally to facilitate diagnosis of a mental illness. We suggest that technology has great potential to improve our diagnostic tools, especially for disorders such as chronic mania the diagnosis of which relies primarily on self-report and collateral information.
  • ||||||||||  aripiprazole / Generic mfg., risperidone / Generic mfg.
    Enrollment closed, Trial completion date, Trial primary completion date:  LAP01: Long-term Antipsychotic Pediatric Safety Trial (clinicaltrials.gov) -  Sep 1, 2021   
    P=N/A,  N=509, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Phase classification: PN/A --> P4 Recruiting --> Active, not recruiting | Trial completion date: Jul 2021 --> Sep 2024 | Trial primary completion date: Jul 2021 --> Sep 2024
  • ||||||||||  risperidone / Generic mfg.
    Clinical, Journal:  Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis. (Pubmed Central) -  Aug 29, 2021   
    Here, we assessed the drug-placebo sensitivity of the six-item subscale (PANSS-6) of the 30-item Positive and Negative Syndrome Scale (PANSS-30) using a large collection of patient-level data (n = 6685) from randomized controlled trials of risperidone and paliperidone...Similarly, early improvement (≥20% improvement at week 1) on the PANSS-6 predicted subsequent response (≥40% improvement at endpoint) as well as the analog prediction using PANSS-30. Finally, cross-sectional symptom remission assessed via the PANSS-6 showed very good agreement (sensitivity = 100%, specificity = 98%) with cross-sectional symptom remission defined by the Remission in Schizophrenia Working Group.
  • ||||||||||  risperidone / Generic mfg., amphetamine / Generic mfg.
    Journal:  Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference. (Pubmed Central) -  Aug 29, 2021   
    The density of forebrain dopamine transporters, a primary target of amphetamine, was also quantified in rats administered risperidone early in life and found to be reduced in the medial anterior, posterior, and ventral caudate nucleus. These results suggest that chronic risperidone treatment modifies later locomotor activity and sensitivity to the reinforcing effects of amphetamine, perhaps via a mechanism related to decreased forebrain dopamine transporter density.
  • ||||||||||  risperidone / Generic mfg.
    Biomarker, Journal:  CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research. (Pubmed Central) -  Aug 28, 2021   
    These results suggest that chronic risperidone treatment modifies later locomotor activity and sensitivity to the reinforcing effects of amphetamine, perhaps via a mechanism related to decreased forebrain dopamine transporter density. No abstract available